Acta Crystallographica Section D Structural Biology,
Journal Year:
2023,
Volume and Issue:
79(2), P. 111 - 121
Published: Jan. 20, 2023
The
COVID-19
pandemic
and
concomitant
lockdowns
presented
a
global
health
challenge
triggered
unprecedented
research
efforts
to
elucidate
the
molecular
mechanisms
pathogenicity
of
SARS-CoV-2.
spike
glycoprotein
decorating
surface
SARS-CoV-2
virions
is
prime
target
for
vaccine
development,
antibody
therapy
serology
as
it
binds
host
cell
receptor
central
viral
entry.
electron
cryo-microscopy
structure
protein
revealed
hydrophobic
pocket
in
receptor-binding
domain
that
occupied
by
an
essential
fatty
acid,
linoleic
acid
(LA).
LA-bound
adopts
non-infectious
locked
conformation
which
more
stable
than
infectious
form
shields
important
immunogenic
epitopes.
Here,
impact
LA
binding
on
infectivity
replication,
evolutionary
conservation
other
highly
pathogenic
coronaviruses,
including
variants
concern
(VOCs),
are
reviewed.
importance
metabolic
products,
eicosanoids,
regulating
human
immune
response
inflammation
highlighted.
Lipid
fatty-acid
proteins
virion
appears
be
broader
strategy
employed
viruses,
picornaviruses
Zika
virus.
Ligand
stabilizes
their
assembly,
downregulates
infectivity.
In
case
rhinoviruses,
this
has
been
exploited
develop
small-molecule
antiviral
drugs
bind
pocket.
results
suggest
treatment
based
LA-binding
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2022,
Volume and Issue:
11
Published: Jan. 18, 2022
The
structural
spike
(S)
glycoprotein
of
severe
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2)
plays
an
essential
role
in
infection
and
is
important
target
for
neutralizing
antibody
recognition.
Mutations
the
S
gene
can
generate
variants
concern
(VOCs),
which
improve
"viral
fitness"
through
selective
or
survival
advantages,
such
as
increased
ACE-2
receptor
affinity,
infectivity,
viral
replication,
higher
transmissibility,
resistance
to
antibodies
immune
escape,
increasing
disease
severity
reinfection
risk.
Five
VOCs
have
been
recognized
include
B.1.1.7
(U.K.),
B.1.351
(South
Africa),
P.1
(Brazil),
B.1.617.2
(India),
B.1.1.529
(multiple
countries).
In
this
review,
we
addressed
following
critical
points
concerning
VOCs:
a)
characteristics
SARS-CoV-2
with
mutations
gene;
b)
possible
evasion
from
generated
vaccination,
previous
infection,
therapies;
c)
potential
risk
new
pandemic
waves
induced
by
worldwide;
d)
perspectives
further
studies
actions
aimed
at
preventing
reducing
impact
during
current
COVID-19
pandemic.
Microbiology and Immunology,
Journal Year:
2021,
Volume and Issue:
66(1), P. 15 - 23
Published: Sept. 25, 2021
Spike
(S)
protein
cleavage
is
a
crucial
step
in
coronavirus
infection.
In
this
review,
process
discussed,
with
particular
focus
on
the
novel
coronavirus,
severe
acute
respiratory
syndrome
2
(SARS-CoV-2).
Compared
influenza
virus
and
paramyxovirus
membrane
fusion
proteins,
activation
mechanism
of
S
much
more
complex.
The
has
two
sites
(S1/S2
S2'),
motif
for
furin
protease
at
S1/S2
site
that
results
from
unique
four-amino
acid
insertion
one
distinguishing
features
SARS-CoV-2.
viral
particle
incorporates
protein,
which
already
undergone
by
furin,
then
undergoes
further
S2'
site,
mediated
type
II
transmembrane
serine
(TMPRSS2),
after
binding
to
receptor
angiotensin-converting
enzyme
(ACE2)
facilitate
plasma
membrane.
addition,
SARS-CoV-2
can
enter
cell
endocytosis
be
proteolytically
activated
cathepsin
L,
although
not
major
mode
variants
enhanced
infectivity
have
been
emerging
throughout
ongoing
pandemic,
there
close
relationship
between
changes
cleavability.
All
four
concern
carry
D614G
mutation,
indirectly
enhances
cleavability
furin.
P681R
mutation
delta
variant
directly
increases
cleavability,
enhancing
virulence.
Changes
significantly
impact
infectivity,
tissue
tropism,
Understanding
these
mechanisms
critical
counteracting
pandemic.
Trends in Molecular Medicine,
Journal Year:
2022,
Volume and Issue:
28(4), P. 319 - 330
Published: Feb. 14, 2022
The
impact
of
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
infection
during
pregnancy
on
the
developing
fetal
brain
is
poorly
understood.
Other
antenatal
infections
such
as
influenza
have
been
associated
with
adverse
neurodevelopmental
outcomes
in
offspring.
Although
vertical
transmission
has
rarely
observed
SARS-CoV-2
to
date,
given
potential
for
profound
maternal
immune
activation
(MIA),
likely.
Here
we
review
evidence
that
and
other
viral
can
result
maternal,
placental,
activation,
ultimately
offspring
morbidity.
Finally,
highlight
need
cellular
models
development
better
understand
short-
long-term
impacts
next
generation.
Nature Communications,
Journal Year:
2022,
Volume and Issue:
13(1)
Published: Oct. 15, 2022
Abstract
In
cultured
cells,
SARS-CoV-2
infects
cells
via
multiple
pathways
using
different
host
proteases.
Recent
studies
have
shown
that
the
furin
and
TMPRSS2
(furin/TMPRSS2)-dependent
pathway
plays
a
minor
role
in
infection
of
Omicron
variant.
Here,
we
confirm
uses
furin/TMPRSS2-dependent
inefficiently
enters
mainly
cathepsin-dependent
endocytosis
TMPRSS2-expressing
VeroE6/TMPRSS2
Calu-3
cells.
This
is
case
despite
efficient
cleavage
spike
protein
Omicron.
However,
airways
TMPRSS2-knockout
mice,
significantly
reduced.
We
furthermore
show
propagation
mouse-adapted
QHmusX
strain
human
clinical
isolates
Beta
Gamma
reduced
mice.
Therefore,
variant
isn’t
an
exception
vivo,
analysis
with
mice
important
when
evaluating
variants.
conclusion,
this
study
shows
critically
for
murine
airways,
including
Frontiers in Virology,
Journal Year:
2022,
Volume and Issue:
1
Published: Jan. 12, 2022
The
ability
of
a
virus
to
spread
between
individuals,
its
replication
capacity
and
the
clinical
course
infection
are
macroscopic
consequences
multifaceted
molecular
interaction
viral
components
with
host
cell.
heavy
impact
COVID-19
on
world
population,
economics
sanitary
systems
calls
for
therapeutic
prophylactic
solutions
that
require
deep
characterization
interactions
occurring
cells.
Unveiling
how
SARS-CoV-2
engages
factors
throughout
life
cycle
is
therefore
fundamental
understand
pathogenic
mechanisms
underlying
design
antiviral
therapies
strategies.
Two
years
into
pandemic,
this
review
provides
an
overview
interplay
cell,
focus
machinery
compartments
pivotal
cellular
response.
Starting
cell
surface,
following
replicative
through
entry
pathways,
survival
in
cytoplasm,
egress
from
infected
unravels
complex
network
highlighting
knowledge
has
potential
set
basis
development
innovative
Signal Transduction and Targeted Therapy,
Journal Year:
2022,
Volume and Issue:
7(1)
Published: Feb. 23, 2022
Abstract
The
coronavirus
disease
2019
(COVID-19)
is
a
highly
transmissible
caused
by
the
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
that
poses
major
threat
to
global
public
health.
Although
COVID-19
primarily
affects
system,
causing
pneumonia
and
distress
in
cases,
it
can
also
result
multiple
extrapulmonary
complications.
pathogenesis
of
damage
patients
with
probably
multifactorial,
involving
both
direct
effects
SARS-CoV-2
indirect
mechanisms
associated
host
inflammatory
response.
Recognition
features
complications
has
clinical
implications
for
identifying
progression
designing
therapeutic
strategies.
This
review
provides
an
overview
from
immunological
pathophysiologic
perspectives
focuses
on
potential
targets
management
COVID-19.
Viruses,
Journal Year:
2022,
Volume and Issue:
14(7), P. 1415 - 1415
Published: June 28, 2022
Molecular
mimicry
between
viral
antigens
and
host
proteins
can
produce
cross-reacting
antibodies
leading
to
autoimmunity.
The
coronavirus
SARS-CoV-2
causes
COVID-19,
a
disease
curiously
resulting
in
varied
symptoms
outcomes,
ranging
from
asymptomatic
fatal.
Autoimmunity
due
molecular
may
provide
an
explanation.
Thus,
we
computationally
investigated
Spike
known
epitopes.
We
discovered
hotspots
highlight
two
examples
with
tentative
high
autoimmune
potential
implications
for
understanding
COVID-19
complications.
show
that
TQLPP
motif
thrombopoietin
shares
similar
antibody
binding
properties.
Antibodies
induce
thrombocytopenia,
condition
observed
patients.
Another
motif,
ELDKY,
is
shared
multiple
human
proteins,
such
as
PRKG1
involved
platelet
activation
calcium
regulation,
tropomyosin,
which
linked
cardiac
disease.
tropomyosin
cause
complications
blood-clotting
disorders
disease,
respectively.
Our
findings
illuminate
pathogenesis
the
importance
of
considering
when
developing
therapeutic
interventions
reduce
adverse
reactions.
The Journal of Infectious Diseases,
Journal Year:
2022,
Volume and Issue:
225(5), P. 754 - 758
Published: Jan. 11, 2022
There
is
limited
information
on
the
specific
impact
of
maternal
infection
with
SARS-CoV-2
B.1.617.2
(delta)
variant
pregnancy
outcomes.
We
present
2
cases
intrauterine
fetal
demise
and
1
case
severe
distress
in
setting
delta-variant
SARS-CoV-2.
In
all
cases,
or
occurred
within
14
days
COVID-19
diagnosis.
Evaluation
revealed
viremia,
high
nasopharyngeal
viral
load,
evidence
placental
SARS-CoV-2,
hallmark
features
placentitis.
suggest
that
during
warrants
vigilance
for
dysfunction
compromise
regardless
disease
severity.
Despite
tremendous
progress
in
the
understanding
of
COVID-19,
mechanistic
insight
into
immunological,
disease-driving
factors
remains
limited.
We
generated
maVie16,
a
mouse-adapted
SARS-CoV-2,
by
serial
passaging
human
isolate.
In
silico
modeling
revealed
how
only
three
Spike
mutations
maVie16
enhanced
interaction
with
murine
ACE2.
induced
profound
pathology
BALB/c
and
C57BL/6
mice,
resulting
mouse
COVID-19
(mCOVID-19)
replicated
critical
aspects
disease,
including
early
lymphopenia,
pulmonary
immune
cell
infiltration,
pneumonia,
specific
adaptive
immunity.
Inhibition
proinflammatory
cytokines
IFNγ
TNF
substantially
reduced
immunopathology.
Importantly,
genetic
ACE2-deficiency
completely
prevented
mCOVID-19
development.
Finally,
inhalation
therapy
recombinant
ACE2
fully
protected
mice
from
mCOVID-19,
revealing
novel
efficient
treatment.
Thus,
we
here
present
as
new
tool
to
model
for
discovery
therapies
show
that
disease
severity
is
determined
cytokine-driven
immunopathology
critically
dependent
on
vivo.
Journal of Virology,
Journal Year:
2022,
Volume and Issue:
96(23)
Published: Nov. 9, 2022
The
appearance
of
new
dominant
variants
concern
(VOC)
severe
acute
respiratory
syndrome
coronavirus
type
2
(SARS-CoV-2)
threatens
the
global
response
to
disease
2019
(COVID-19)
pandemic.
Of
these,
alpha
variant
(also
known
as
B.1.1.7),
which
appeared
initially
in
United
Kingdom,
became
much
Europe
and
North
America
first
half
2021.
spike
(S)
glycoprotein
acquired
seven
mutations
two
deletions
compared
ancestral
virus,
including
P681H
mutation
adjacent
polybasic
cleavage
site,
has
been
suggested
enhance
S
cleavage.
Here,
we
show
that
protein
confers
a
level
resistance
beta
interferon
(IFN-β)
human
lung
epithelial
cells.
This
correlates
with
an
entry
restriction
mediated
by
interferon-induced
transmembrane
(IFITM2)
pronounced
infection
enhancement
IFITM3.
Furthermore,
is
essential
for
IFN-β
context-dependent
IFITMs
S.
reduces
dependence
on
endosomal
cathepsins,
consistent
enhanced
cell
surface
entry.
However,
reversion
H681
does
not
reduce
cleaved
incorporation
into
particles,
indicating
it
exerts
its
effect
downstream
furin
Overall,
suggest
that,
addition
adaptive
immune
escape,
associated
VOC
may
well
also
confer
replication
and/or
transmission
advantage
through
adaptation
resist
innate
mechanisms.